Skip to main content

Relapse Prevention and Maintaining Abstinence in Older Adults with Alcohol-Use Disorders

Drugs & Aging volume 19, pages 583–594 (2002)Cite this article

Abstract

Although older adults are sometimes believed to have the lowest rates of alcohol abuse as an age cohort, the prevalence of alcohol use and abuse in this group is clearly underestimated. The under-diagnosis of alcohol abuse is due, in part, to the facts that the effects of alcohol use among older adults tend to be less clearly visible than among other age groups and that older adults are less likely to seek treatment than younger age groups. An additional challenge to diagnosis may be a lack of previous alcohol abuse by the patient, as approximately one-third of older adults with alcohol-use problems first develop their drinking problem after the age of 60 years. With a demographic shift that is expected to increase the number of older adults with alcohol problems, the awareness and understanding of this problem becomes increasingly important.

Under-diagnosis of problem drinking in older adults is particularly unfortunate because the risks associated with alcohol abuse and relapse for the elderly are significant. Relapse, or the return to drinking following abstinence, may follow situations that are of particularly high risk for older adults. These include situations related to anxiety, interpersonal conflict, depression, loneliness, loss or social isolation. By helping patients to monitor these high-risk situations, to identify strategies that have been successful in promoting abstinence in the past, and to become engaged in treatment, relapse may be avoided and abstinence maintained.

Treatments such as cognitive-behavioural therapy, group and family therapies and self-help groups are just as effective for older adults as they are for other age groups. In fact, group and family therapies and self-help groups may be of particular benefit to older adults because of the emphasis on social support. Medicinal adjuncts are also equally effective in the elderly, but strict compliance and careful monitoring of adverse effects are especially important in patients who take multiple medications. Because of their benign adverse effect profiles, naltrexone and acamprosate are particularly good pharmacological agents for relapse prevention in older adults.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Table I

References

  1. American Psychological Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA, 1994

    Google Scholar 

  2. World Health Organization. The ICD-10 classification of mental and behavioral disorders. Geneva: WHO, 1992

    Google Scholar 

  3. Johnson I. Alcohol problems in old age: a review of recent epidemiological research. Int J Geriatr Psychiatry 2000; 15: 575–81

    PubMed  Article  CAS  Google Scholar 

  4. Allen D, Landis R. Substance abuse in elderly individuals. In: Nussbaum D, editor. The handbook of neuropsychology and aging. New York (NY): Plenum Press, 1997

    Google Scholar 

  5. Patterson T, Jeste D. The potential impact of the baby-boom generation on substance abuse among elderly persons. J Ment Health Aging 1999; 50: 1184–8

    CAS  Google Scholar 

  6. Office of Population Censuses and Surveys. Living in Britain: results from the 1994 general household survey. London: HMSO, 1996

    Google Scholar 

  7. MacNeil P, Webster I. Canada’s alcohol and other drugs survey: a discussion of the findings. Ottawa (ONT): Office of Alcohol, Drugs, and Dependency Issues, 1994

    Google Scholar 

  8. National Institute on Alcohol Abuse and Alcoholism. Ninth special report to the United States Congress on alcohol and health. Washington (DC): US Government Printing Office, 1997

    Google Scholar 

  9. Giordano J, Beckham K. Alcohol use and abuse in old age: an examination of type II alcoholism. J Gerontol Soc Work 1985; 9(1): 65–83

    Article  Google Scholar 

  10. Chermack ST, Blow FC, Hill EM, et al. The relationship between alcohol symptoms and consumption among older drinkers. Alcohol Clin Exp Res 1996; 20: 1153–8

    PubMed  Article  CAS  Google Scholar 

  11. Blow F, Cook C, Booth B, et al. Age-related psychiatric comorbidities and level of functioning in alcoholic veterans seeking outpatient treatment. Hosp Community Psychiatry 1992; 43: 990–5

    PubMed  CAS  Google Scholar 

  12. Schonfeld L, Dupree L. Alcohol use and misuse in older adults. Rev Clin Gerontol 1999; 9: 151–62

    Article  Google Scholar 

  13. Bucholz K, Sheline Y, Heltzer J. The epidemiology of alcohol use, problems, and dependence in elders: a review. In: Beresford T, Gomberg E, editors. Alcohol and aging. New York (NY): Oxford University Press, 1995

    Google Scholar 

  14. Liberto J, Oslin D, Ruskin P. Alcoholism in older persons: a review of the literature. Hosp Community Psychiatry 1992; 43: 975–84

    PubMed  CAS  Google Scholar 

  15. Joseph C. Misuse of alcohol and drugs in the nursing home. In: Gurnack A, editor. Older adults’ misuse of alcohol, medicines, and other drugs: research and practice issues. New York (NY): Springer Publishing Co, Inc, 1997: 228–54

    Google Scholar 

  16. Gomberg E, Zucker R. Substance use and abuse in old age. In: Nordhus I, VandenBos G, Berg S, et al., editors. Clinical geropsychology. Washington (DC): American Psychological Association, 1998

    Google Scholar 

  17. Liberto J, Oslin D. Early versus late onset of alcoholism in the elderly. In: Gurnack A, editor. Drugs and the elderly: use and abuse of drugs, medicines, alcohol, and tobacco. New York (NY): Springer, 1996

    Google Scholar 

  18. Sobell M, Sobell L. Controlled drinking after 25 years: how important was the great debate? Addiction 1995; 90: 1149–53

    PubMed  Article  CAS  Google Scholar 

  19. Marlatt GA, Gordon JR. Relapse prevention. New York (NY): The Guilford Press, 1985

    Google Scholar 

  20. Litman GK. Relapse in alcoholism: traditional and current approaches. In: Edwards G, Grant M, editors. Alcoholism treatment in transition. Baltimore (MD): University Park Press, 1980

    Google Scholar 

  21. Hunt WA, Barnett W, Branch LG. Relapse rates in addiction programs. J Clin Psychol 1971; 27: 455–6

    PubMed  Article  CAS  Google Scholar 

  22. Armor D, Polich J, Stambul H. Alcoholism and treatment. New York (NY): Wiley, 1978

    Google Scholar 

  23. Orford J, Edwards G. Alcoholism: a comparison of treatment and advice, with a study of influence of marriage (Maudsley Monographs No. 26). New York (NY): Oxford University Press, 1977

    Google Scholar 

  24. Moos RH, Finney JW, Cronkite RC. Alcoholism treatment: context, process and outcome. New York (NY): Oxford University Press, 1990

    Google Scholar 

  25. Polich JM, Armor DJ, Braiker HB. The course of alcoholism: four years after treatment. New York (NY): Wiley, 1981

    Google Scholar 

  26. Janik SW, Dunham RG. A nationwide examination of the need for specific alcoholism treatment programs for the elderly. J Stud Alcohol 1983; 44: 307–17

    PubMed  CAS  Google Scholar 

  27. Marlatt GA, Gordon JR. Determinants of relapse: implications for the maintenance of behavior change. In: Davidson PO, Davidson SM, editors. Behavioral medicine: changing health lifestyles. New York (NY): Brunner/Mazel, 1980: 410–52

    Google Scholar 

  28. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84: 191–215

    PubMed  Article  CAS  Google Scholar 

  29. Lowman C, Allen J, Stout RL, et al. Replication and extension of Marlatt’s taxonomy of relapse precipitants: overview of procedures and results. Addiction 1996; 91: S51–71

    PubMed  Article  Google Scholar 

  30. Schonfeld L, Dupree L, Rohrer G. Age-related differences between younger and older alcohol abusers. J Clin Gerontol 1995; 1: 219–27

    Google Scholar 

  31. Brown SA, Goldman MS, Inn A, et al. Expectations of reinforcement from alcohol: their domain and relation to drinking patterns. J Consult Clin Psychol 1980; 48: 419–26

    PubMed  Article  CAS  Google Scholar 

  32. Storandt M, VandenBos G. Neuropsychological assessment of dementia and depression. Washington (DC): American Psychological Association, 1995

    Google Scholar 

  33. Rice C, Longabaugh R, Beattie M, et al. Age group differences in response to treatment for problematic alcohol use. Addiction 1993; 88: 1369–75

    PubMed  Article  CAS  Google Scholar 

  34. McKay JR, Maisto SA, O’Farrell TJ. Alcoholics’ perceptions of factors in the onset and termination of relapses and the maintenance of abstinence: results from a 30-month follow-up. Psychol Addict Behav 1996; 10: 167–80

    Article  Google Scholar 

  35. Connors GJ, Maisto SA, Zywiak WH. Male and female alcoholics’ attributions regarding the onset and termination of relapses and the maintenance of abstinence. J Subst Abuse 1998; 10: 27–42

    PubMed  Article  CAS  Google Scholar 

  36. Connors GJ, Maisto SA, Zywiak WH. Understanding relapse in the broader context of posttreatment functioning. Addiction 1996; 91: S173–89

    PubMed  Article  Google Scholar 

  37. Litman GK, Eiser JR, Rawson NSB, et al. Towards a typology of relapse: differences in relapse and coping behaviours between alcoholic relapsers and survivors. Behav Res Ther 1979; 17: 89–94

    PubMed  Article  CAS  Google Scholar 

  38. Blow F, Walton M, Barry K, et al. The relationship between alcohol problems and health functioning of older adults in primary care settings. J Am Geriatr Soc 2000; 48: 769–74

    PubMed  CAS  Google Scholar 

  39. Brower K, Mudd S, Blow F, et al. Severity and treatment of alcohol withdrawal in elderly versus younger patients. Alcohol Clin Exp Res 1994; 18: 196–201

    PubMed  Article  CAS  Google Scholar 

  40. Oslin D, Liberto J, O’Brien J, et al. Naltrexone as an adjunctive treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry 1997; 5: 324–32

    PubMed  Article  CAS  Google Scholar 

  41. Monti P, Abrams D, Kadden R, et al. Treating alcohol dependence: a coping skills training guide. New York (NY): The Guilford Press, 1989

    Google Scholar 

  42. Nirenberg T, Lisansky-Gomberg E, Cellucci T. Substance abuse disorders. In: Hersen M, Van Hasselt V, editors. Handbook of clinical geropsychology: the Plenum series in adult development and aging. New York (NY): Plenum Press, 1998

    Google Scholar 

  43. Dupree L, Broskowski H, Scholfeld L. The gerontology alcohol project: a behavioral program for elderly alcohol abusers. Gerontologist 1984; 24: 510–6

    PubMed  Article  CAS  Google Scholar 

  44. Johnson L. How to diagnose and treat chemical dependency in the elderly. J Gerontol Nurs 1989; 15: 22–6

    Google Scholar 

  45. Zimberg S. The elderly. In: Washton A, editor. Psychotherapy and substance abuse. New York (NY): The Guilford Press, 1995

    Google Scholar 

  46. Swift RM. Drug therapy for alcohol dependence. N Engl J Med 1999; 340: 1482–90

    PubMed  Article  CAS  Google Scholar 

  47. Kranzler H. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol 2000; 35: 537–47

    PubMed  CAS  Google Scholar 

  48. Brewer C, Meyers R Johnsen J. Does disulfiram help to prevent relapse in alcohol abuse? CNS Drugs 2000; 14: 329–41

    Article  CAS  Google Scholar 

  49. Chick J, Gough K, Falkowski W, et al. Disulfiram treatment for alcoholism. Br J Psychiatry 1993; 161: 84–9

    Article  Google Scholar 

  50. Brewer C. How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice. Br J Psychiatry 1984; 144: 200–2

    PubMed  Article  CAS  Google Scholar 

  51. Fuller R, Branchey L, Brightwell D. Disulfiram treatment of alcoholism: a veterans administration cooperative study. JAMA 1986; 256: 1449–55

    PubMed  Article  CAS  Google Scholar 

  52. Johnsen J, Morland J. Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome. Alcohol Clin Exp Res 1991; 15: 532–6

    PubMed  Article  CAS  Google Scholar 

  53. O’Farrell T, Allen J, Litten R. Disulfiram (antabuse) contracts in treatment of alcoholism. NIDA Res Monogr 1995; 150: 65–91

    PubMed  Google Scholar 

  54. Garbutt J, West S, Carey T, et al. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 1999; 281: 1318–25

    PubMed  Article  CAS  Google Scholar 

  55. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology 1997; 129: 99–111

    PubMed  Article  CAS  Google Scholar 

  56. King A, Volpicelli J, Frazer A, et al. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 1997; 129: 15–22

    PubMed  Article  CAS  Google Scholar 

  57. Swift R, Whelihan W, Kuznetsov O, et al. Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 1994; 151: 1463–7

    PubMed  CAS  Google Scholar 

  58. Volpicelli J, Watson N, King A, et al. Effect of naltrexone on alcohol “high” in alcoholics. Am J Psychiatry 1995; 152: 613–5

    PubMed  CAS  Google Scholar 

  59. Monti P, Rohsenow D, Hutchison K, et al. Naltrexone’s effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 1999; 23: 1386–94

    PubMed  CAS  Google Scholar 

  60. Davidson D, Swift R, Fitz E. Naltrexone increases the latency to drink alcohol in social drinkers. Alcohol Clin Exp Res 1996; 20: 732–9

    PubMed  Article  CAS  Google Scholar 

  61. Mason B, Ritvo E, Morgan R, et al. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 1994; 18: 1162–7

    PubMed  Article  CAS  Google Scholar 

  62. O’Malley S, Jaffee A, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992; 40: 894–8

    Google Scholar 

  63. Tempesta E, Janiri L, Bignamini A, et al. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Pharmacopsychiatry 2000; 29: 27–9

    Google Scholar 

  64. Whitworth A, Fischer F, Lesch OM, et al. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 1996; 347: 1438–42

    PubMed  Article  CAS  Google Scholar 

  65. Geerlings PJ, Ansoms C, van den Brink W. Acamprosate and prevention of relapse in alcoholics: results of a randomized, placebo controlled, double-blind study in out-patient alcoholics in the Netherlands, Belgium and Luxembourg. Eur Addict Res 1997; 3(3): 129–37

    Article  Google Scholar 

  66. Lhuintre JP, Moore ND, Tran G, et al. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 1990; 25(6): 613–22

    PubMed  CAS  Google Scholar 

  67. Paille FM, Guelfi JD, Perkins AC, et al. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol 1995; 30(2): 239–47

    CAS  Google Scholar 

  68. Pelc I, Verbanck P, LeBon O, et al. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo controlled dose-finding study. Br J Psychiatry 1997; 171: 73–7

    PubMed  Article  CAS  Google Scholar 

  69. Sass H, Soyka M, Mann K, et al. Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 1996; 53(8): 673–80

    PubMed  Article  CAS  Google Scholar 

  70. Soyka M. Clinical efficacy of acamprosate in the treatment of alcoholism. In: Soyka M, editor. Acamprosate in relapse prevention of alcoholism. Berlin: Springer-Verlag, 1996: 155–71

    Chapter  Google Scholar 

  71. Saivin S, Hulot T, Chabac S, et al. Clinical pharmacokinetics of acamprosate. Clin Pharmacokinet 1998; 35(5): 331–45

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgements

Preparation of this manuscript was supported, in part, with funding awarded as part of a grant from the US National Institute on Alcohol Abuse and Alcoholism (NIAAA) to the Research Institute of Addictions, University at Buffalo (Award No. AA11529).

Author information

Affiliations

  1. Research Institute on Addictions, University at Buffalo, 1021 Main Street, Buffalo, New York, 14203, USA

    Christopher Barrick & Gerard J. Connors

Authors
  1. Christopher Barrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerard J. Connors
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher Barrick.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Barrick, C., Connors, G.J. Relapse Prevention and Maintaining Abstinence in Older Adults with Alcohol-Use Disorders. Drugs Aging 19, 583–594 (2002). https://doi.org/10.2165/00002512-200219080-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200219080-00004

Keywords

  • Alcohol Abuse
  • Naltrexone
  • Family Therapy
  • Alcohol Problem
  • Relapse Prevention